Transformation Leader with Full-Spectrum Supply Chain and Manufacturing Fluency and Successful Record of Architecting and Implementing Growth-Management Strategies


End-to-End Supply Chain Management

Pharmaceutical Manufacturing Operations

Strategic Negotiations

Outsourcing/Network Optimization

Product Launch

Commercial Operations

Organizational Transformation

Operational Excellence - Lean Six Sigma


xCell Strategic Consulting – Principal

Edwards Lifesciences – VP, GSC Strategy and Execution

Daiichi Sankyo – VP, Supply Chain and Tech-Ops

Sankyo – Executive Director, Supply Chain and Commercial Operations

American Cyanamid – Regional Logistics Head


Executive Advisor and Member, International Society for Pharmaceutical Engineering (ISPE)

Member, Association for Operations Management (APICS)

Lean Six Sigma Certified


BA, Business/Economics, William Paterson University



Jeffrey C. Lane, Principal

Jeff is a global pharmaceutical executive with over 25 years of experience in supply chain, manufacturing and commercial operations. He was instrumental in transforming a startup into a fully-integrated multi-billion-dollar division of a Top 20 pharmaceutical company. He has deep expertise in end-to-end supply chain management and a demonstrated record of designing and implementing operational strategies to achieve commercialization goals.

A leader with multi-cultural acumen and a panoramic understanding of the value chain, Jeff built and led high-performing teams across the clinical-to-commercial supply continuum. He engineered the successful turnaround of underperforming operations and architected a multi-year supply chain transformation involving several regional business units. He’s a champion for best-in-class process and a driver of operational excellence.


  • Led high-performing team responsible for the execution of all supply chain activities required to commercialize a $3B portfolio of cardiovascular products.
  • Gained board approval for implementing a center-led supply chain construct to leverage best practices, create standards, generate $30MM in synergies and improve utilization of group company assets.
  • Championed and implemented a best-in-class Executive S&OP process resulting in 80 to 100% improvement in forecast error, forecast bias and adherence to inventory plan within five months.
  • Led the acquisition, renovation, integration and ongoing operations of company’s first NA-based production facility. Passed initial and subsequent bi-annual inspection with zero 483 observations.
  • Established Lean Six Sigma as continuous improvement platform, implemented visual factory metrics and improved OEE by 10%.
  • Led organization that achieved 97% first-pass quality, 99% on-time delivery and 90% adherence to inventory plan despite overselling and constraints from the earthquake in Japan.
  • Flawlessly executed manufacturing and supply strategies to enable the commercial launch of eight cardiovascular products within 24 to 48 hours of FDA label approval.
  • Achieved aggressive commercialization timeline for fixed-dose combination of two anti-hypertensive agents by spearheading and leading parallel formulation development project.